CNR Institutional Research Information System

DI MARZO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.636
NA - Nord America 5.221
SA - Sud America 3.112
EU - Europa 2.710
AF - Africa 280
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 27.983
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 7.384
US - Stati Uniti d'America 4.899
CN - Cina 3.432
BR - Brasile 2.559
HK - Hong Kong 1.996
VN - Vietnam 1.563
FR - Francia 985
KR - Corea 682
IT - Italia 643
JP - Giappone 417
IN - India 264
NL - Olanda 214
AR - Argentina 203
BD - Bangladesh 184
GB - Regno Unito 165
DE - Germania 151
FI - Finlandia 149
CA - Canada 118
MX - Messico 105
ID - Indonesia 103
IL - Israele 103
EC - Ecuador 98
ZA - Sudafrica 86
IQ - Iraq 73
TR - Turchia 68
PK - Pakistan 64
UA - Ucraina 62
CO - Colombia 60
SA - Arabia Saudita 57
RU - Federazione Russa 46
ES - Italia 43
VE - Venezuela 43
MA - Marocco 41
PY - Paraguay 40
UZ - Uzbekistan 39
CL - Cile 38
PE - Perù 37
AT - Austria 36
EG - Egitto 34
PL - Polonia 33
KE - Kenya 25
TN - Tunisia 24
UY - Uruguay 23
JM - Giamaica 22
PH - Filippine 22
SE - Svezia 22
AZ - Azerbaigian 20
DZ - Algeria 19
IE - Irlanda 19
MY - Malesia 19
JO - Giordania 16
TT - Trinidad e Tobago 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
BG - Bulgaria 13
NP - Nepal 13
DO - Repubblica Dominicana 12
TH - Thailandia 12
BE - Belgio 10
RO - Romania 10
TW - Taiwan 10
AL - Albania 9
HU - Ungheria 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
CR - Costa Rica 8
DK - Danimarca 8
HN - Honduras 8
KZ - Kazakistan 8
LB - Libano 8
PT - Portogallo 8
RS - Serbia 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
LT - Lituania 7
OM - Oman 7
EE - Estonia 6
GT - Guatemala 6
NG - Nigeria 6
SV - El Salvador 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
CH - Svizzera 5
CY - Cipro 5
ET - Etiopia 5
GA - Gabon 5
GE - Georgia 5
KG - Kirghizistan 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PA - Panama 5
PR - Porto Rico 5
QA - Qatar 5
AM - Armenia 4
AO - Angola 4
GR - Grecia 4
HR - Croazia 4
KH - Cambogia 4
MD - Moldavia 4
Totale 27.908
Salva come PNG Salva come JPEG
Città #
Singapore 4.394
Hong Kong 1.973
Hefei 1.604
Santa Clara 1.197
San Jose 864
Lauterbourg 836
Seoul 666
Ho Chi Minh City 577
Beijing 514
Ashburn 414
Hanoi 363
Tokyo 304
Los Angeles 234
Dallas 179
São Paulo 175
New York 145
Naples 98
Minamishinagawa 92
Helsinki 87
Rio de Janeiro 84
Da Nang 81
Rome 62
Haiphong 61
Brasília 60
Buffalo 60
Council Bluffs 58
Guangzhou 58
Bengaluru 57
Lappeenranta 50
Frankfurt am Main 46
Belo Horizonte 45
Curitiba 45
Milan 42
Dhaka 41
Nuremberg 40
Biên Hòa 39
Guarulhos 35
Campinas 34
Johannesburg 34
Phoenix 34
Tashkent 34
Porto Alegre 33
Quito 33
Orem 32
Baghdad 29
Afragola 28
Salvador 28
Shanghai 28
Elk Grove Village 26
Houston 26
Mexico City 25
Warsaw 25
Chennai 24
London 24
Shenzhen 23
Asunción 22
Atlanta 22
Guayaquil 22
Hải Dương 22
Lima 22
Casandrino 21
Chicago 21
Fortaleza 21
Nairobi 21
Osasco 21
Thái Bình 21
Cairo 20
Bắc Ninh 19
Goiânia 19
Ribeirão Preto 19
Brooklyn 18
Buenos Aires 18
Bắc Giang 18
Jakarta 18
Montreal 18
Quận Bình Thạnh 18
Thái Nguyên 18
Toronto 18
Amsterdam 17
Cape Town 17
Istanbul 17
Jeddah 17
Montevideo 17
Ninh Bình 17
Santo André 17
Uberlândia 17
Can Tho 16
Dublin 16
Mumbai 16
Nanjing 16
Riyadh 16
Sorocaba 16
Vienna 16
Amman 15
Baku 15
Betim 15
Caxias do Sul 15
Charlotte 15
Lahore 15
Manchester 15
Totale 17.010
Salva come PNG Salva come JPEG
Nome #
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 103
y The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil 100
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. 97
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 97
Short and efficient synthesis of alkylresorcinols: a route for the preparation of cannabinoids 93
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice 91
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis 85
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 83
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 81
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 79
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 77
The short-chain fatty acid acetate modulates orexin/hypocretin neurons: A novel mechanism in gut-brain axis regulation of energy homeostasis and feeding 77
Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier 74
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors 74
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 74
A sustainable protocol for the synthesis of N-acyl tryptamines, a class of potential gut microbiota-derived endocannabinoid-like mediators 73
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop 72
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 72
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 72
Olive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity 71
Human gut microbiota and their production of endocannabinoid-like mediators are directly affected by a dietary oil 71
Anandamide: Endocannabinoid, endovanilloid, or both? 70
Lipidic secondary metabolites as endogenous regulators or pharmacological tools in Hydrozoan development 70
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 70
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. 69
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson s disease 69
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington?s disease 69
Biosynthesis of the novel endogenous 15-lipoxygenase metabolites N-13-hydroxy-octodecadienoyl-ethanolamine and 13-hydroxy-octodecadienoyl-glycerol by human neutrophils and Eosinophils 69
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 68
Oral Ultramicronized Palmitoylethanolamide:Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect 68
Cannabinoids and the expanded endocannabinoid system in neurological disorders 68
Enantioselective synthesis of 1-(R)-hydroxypolygodial and its 9 Ñ epimer, 1-(R)-hydroxyisotadeonal 67
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 67
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity 67
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain 67
Endocannabinoid-based drugs with multiple sites of action: riding several horses against inflammation and hyper-reactivity 66
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 66
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 66
Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice:relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance 66
Endocannabinoid chemical biology: a tool for the development of novel therapies 65
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 65
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 65
Cannabinoids 64
Pharmacological preparation for topical use containing npalmitoyl-vanillamide 64
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 64
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. 63
The cannabimimetic eicosanoid, anandamide, regulated rat brain protein kinase C and mouse macrophage arachidonate release 63
N-palmitoyl-d-glucosamine, a natural monosaccharide-based glycolipid, inhibits tlr4 and prevents lps-induced inflammation and neuropathic pain in mice 63
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis 63
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. 62
CB1, but not CB2, mediates stimulation of bone formation induced by traumatic brain injury. 62
Phytocannabinoids in the treatment of cancer 62
Pharmacological preparation for topical use containing n-palmitoyl-vanillamide 61
Enantiospecific synthesis of bioactive hydroxyeicosatetraenoic acids (HETEs) in Hydra magnipapillata. 61
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes 61
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity (vol 55, pg 1799, 2016) 60
The gut microbiome, endocannabinoids and metabolic disorders. 60
Prostamide F2a receptor antagonists with inhibitory activity at FAAH: a way to prevent the confounding effects of pro-inflammatory mediators formed following selective FAAH inhibition? 60
Acute Kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic rats 60
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1 60
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 60
Nanoparticle-mediated cellular uptake-controlled release as a tool to study anandamide membrane transport 58
Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors 58
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 58
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome 58
Early endocannabinoid-mediated depolarization-induced suppression of excitation delays the appearance of the epileptic phenotype in synapsin II knockout mice 58
Method for treating pain 1831Prov1 57
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent. 57
Validation of a fast and sensitive UPLC-MS/MS quantitative method for N-acyl taurine analysis in biological samples 57
Potential use of cannabimimetics in the treatment of cancer 56
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease 56
Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase 55
Targeted Lipidomics Investigation of N-acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study 55
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin 55
Cannabinoid CB1 receptor activation inhibits MPTP-induced expression of S100B in glial cells thereby leading to survival of co-cultured neurons. Mechanism of action and involvement of endocannabinoids 54
The endocannabinoid system in principal forebrain neurons protects against excitotoxicity. 54
Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. 54
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret 54
Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes 54
Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. 53
'Endocannabinoids', endogenous phospholipid-derived metabolites with cannabimimetic properties: biosynthesis and catabolism 53
First separation of commendamide enantiomers 53
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 53
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo 53
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling 53
Manipulation of dietary amino acids prevents and reverses obesity in mice through multiple mechanisms that modulate energy homeostasis 53
Life-long epigenetic programming of cortical architecture by maternal 'Western' diet during pregnancy 53
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators 53
In vitro and in vivo pharmacology of synthetic olivetol-derived cannabinoid receptor ligands. 52
Why do cannabinoid receptors have more than one endogenous ligand? 52
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 52
Anandamide and decidual remodelling: COX-2 oxidative metabolism as a key regulator 52
Mechanisms underlying in vivo neuroprotection by anandamide and the CB1/VR1 hybrid agonist arvanil 52
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects 52
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy 52
Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new pparα agonists 52
1.Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. 52
Anandamide receptors 51
Oxidative metabolism of lipoamino acids and vanilloids by lipoxygenases and cyclooxygenases 51
Novel selective and metabolically stable inhibitors of anandamide cellular uptake 51
Totale 6.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.541
article - articoli 77.018
book - libri 239
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.860
Totale 179.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024237 0 0 0 0 0 0 0 0 12 31 70 124
2024/20259.827 57 62 875 575 1.139 145 52 342 273 325 3.098 2.884
2025/202618.182 912 1.720 1.973 2.903 3.201 596 3.034 1.119 1.167 882 675 0
Totale 28.246